Annual Total Expenses
$172.87 M
+$57.71 M+50.12%
December 31, 2023
Summary
- As of February 7, 2025, AKRO annual total expenses is $172.87 million, with the most recent change of +$57.71 million (+50.12%) on December 31, 2023.
- During the last 3 years, AKRO annual total expenses has risen by +$92.72 million (+115.67%).
- AKRO annual total expenses is now at all-time high.
Performance
AKRO Total Expenses Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Quarterly Total Expenses
$81.70 M
+$15.96 M+24.28%
September 30, 2024
Summary
- As of February 7, 2025, AKRO quarterly total expenses is $81.70 million, with the most recent change of +$15.96 million (+24.28%) on September 30, 2024.
- Over the past year, AKRO quarterly total expenses has increased by +$35.09 million (+75.27%).
- AKRO quarterly total expenses is now at all-time high.
Performance
AKRO Quarterly Total Expenses Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Total Expenses Formula
Total Expenses = Cost of Goods Sold + Operating Expenses + Non Operating Expenses
AKRO Total Expenses Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | +50.1% | +75.3% |
| 3 y3 years | +115.7% | +235.5% |
| 5 y5 years | +1154.7% | +401.0% |
AKRO Total Expenses Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3-year | at high | +71.3% | at high | +221.4% |
| 5 y | 5-year | at high | +278.7% | at high | +560.0% |
| alltime | all time | at high | +1154.7% | at high | >+9999.0% |
Akero Therapeutics Total Expenses History
| Date | Annual | Quarterly |
|---|---|---|
| Sep 2024 | - | $81.70 M(+24.3%) |
| Jun 2024 | - | $65.74 M(+9.7%) |
| Mar 2024 | - | $59.95 M(-3.1%) |
| Dec 2023 | $172.87 M(+50.1%) | $61.87 M(+32.7%) |
| Sep 2023 | - | $46.62 M(+30.8%) |
| Jun 2023 | - | $35.63 M(+23.9%) |
| Mar 2023 | - | $28.75 M(+13.1%) |
| Dec 2022 | $115.16 M(+14.1%) | $25.42 M(-29.6%) |
| Sep 2022 | - | $36.09 M(+30.8%) |
| Jun 2022 | - | $27.59 M(+5.9%) |
| Mar 2022 | - | $26.05 M(-19.7%) |
| Dec 2021 | $100.89 M | $32.44 M(+33.2%) |
| Sep 2021 | - | $24.35 M(-15.9%) |
| Date | Annual | Quarterly |
|---|---|---|
| Jun 2021 | - | $28.97 M(+91.5%) |
| Mar 2021 | - | $15.13 M(-49.2%) |
| Dec 2020 | $80.15 M(+75.6%) | $29.78 M(+38.3%) |
| Sep 2020 | - | $21.54 M(+30.9%) |
| Jun 2020 | - | $16.45 M(+32.9%) |
| Mar 2020 | - | $12.38 M(-23.7%) |
| Dec 2019 | $45.65 M(+231.3%) | $16.22 M(-0.5%) |
| Sep 2019 | - | $16.31 M(+114.3%) |
| Jun 2019 | - | $7.61 M(+38.0%) |
| Mar 2019 | - | $5.51 M(+85.7%) |
| Dec 2018 | $13.78 M | $2.97 M(+71.9%) |
| Sep 2018 | - | $1.73 M(-80.1%) |
| Jun 2018 | - | $8.66 M(+1957.5%) |
| Mar 2018 | - | $421.00 K |
FAQ
- What is Akero Therapeutics annual total expenses?
- What is the all time high annual total expenses for Akero Therapeutics?
- What is Akero Therapeutics annual total expenses year-on-year change?
- What is Akero Therapeutics quarterly total expenses?
- What is the all time high quarterly total expenses for Akero Therapeutics?
- What is Akero Therapeutics quarterly total expenses year-on-year change?
What is Akero Therapeutics annual total expenses?
The current annual total expenses of AKRO is $172.87 M
What is the all time high annual total expenses for Akero Therapeutics?
Akero Therapeutics all-time high annual total expenses is $172.87 M
What is Akero Therapeutics annual total expenses year-on-year change?
Over the past year, AKRO annual total expenses has changed by +$57.71 M (+50.12%)
What is Akero Therapeutics quarterly total expenses?
The current quarterly total expenses of AKRO is $81.70 M
What is the all time high quarterly total expenses for Akero Therapeutics?
Akero Therapeutics all-time high quarterly total expenses is $81.70 M
What is Akero Therapeutics quarterly total expenses year-on-year change?
Over the past year, AKRO quarterly total expenses has changed by +$35.09 M (+75.27%)